Topic: Cephalon Inc.
NEW YORK (Reuters) - European health regulators recommended on Thursday restricting the use of Cephalon's sleep disorder drug Provigil for treating narcolepsy only, over concerns that risks may outweigh the benefits of the medicine in other uses. The European Medicines Agency said ...
Cephalon executive VP of worldwide pharmaceutical operations Robert Roche resigningBiotechnology company Cephalon Inc. said Friday its executive vice president of worldwide pharmaceutical operations, Robert P. Roche Jr., to pursue " other longstanding interests. "The resignation is effective Feb. 5. Roche has headed ...
Cephalon sues Watson Pharmaceuticals over generic version of sleep disorder drug NuvigilCephalon Inc. on Wednesday confirmed it is suing generic drug developer Watson Pharmaceuticals Inc. over that company's plan to make a generic version of Cephalon's sleep disorder drug Nuvigil.Cephalon is already ...
Cephalon says FDA decision on Nuvigil as treatment for jet lag is now due March 29The Food and Drug Administration needs more time to review Cephalon Inc.'s drug Nuvigil as a treatment for jet lag, Cephalon said Monday.Cephalon is seeking approval to ...